UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 131

Sortiert nach

Evaluation of Deep Learning Architectures for Complex Immunofluorescence Nuclear Image Segmentation

IEEE transactions on medical imaging, 2021-07, Vol.40 (7), p.1934-1949

2021

Volltextzugriff (PDF)

T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized by Reversible Suppression of T-cell Receptor Signaling

Clinical cancer research, 2018-02, Vol.24 (4), p.870-881

2018

Volltextzugriff (PDF)

Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma

Haematologica (Roma), 2014-03, Vol.99 (3), p.497

2014

Volltextzugriff (PDF)

Correction: Whole exome sequencing of high-risk neuroblastoma identifies novel non-synonymous variants

PloS one, 2024-07, Vol.19 (7), p.e0306687

2024

Volltextzugriff (PDF)

Whole exome sequencing of high-risk neuroblastoma identifies novel non-synonymous variants

PloS one, 2022-08, Vol.17 (8), p.e0273280

2022

Volltextzugriff (PDF)

Whole exome sequencing of high-risk neuroblastoma identifies novel non-synonymous variants

PloS one, 2022-08, Vol.17 (8), p.e0273280

2022

Volltextzugriff (PDF)

Early‐phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning Meeting

Cancer, 2022-11, Vol.128 (21), p.3775-3783

2022

Volltextzugriff (PDF)

Evaluation of clinical parameters and biomarkers in older, untreated mantle cell lymphoma patients receiving bendamustine-rituximab

British journal of haematology, 2024-01, Vol.204 (1), p.160-170

2024

Volltextzugriff (PDF)

11q Deletion or ALK Activity Curbs DLG2 Expression to Maintain an Undifferentiated State in Neuroblastoma

Cell reports (Cambridge), 2020-09, Vol.32 (12), p.108171-108171, Article 108171

2020

Volltextzugriff (PDF)

An annotated fluorescence image dataset for training nuclear segmentation methods

Scientific data, 2020-08, Vol.7 (1), p.262-262, Article 262

2020

Volltextzugriff (PDF)

Plasmacytoid Dendritic Cells (Natural Interferon- α/β-Producing Cells) Accumulate in Cutaneous Lupus Erythematosus Lesions

The American journal of pathology, 2001-07, Vol.159 (1), p.237-243

2001

Volltextzugriff (PDF)

High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease

Blood, 2010-10, Vol.116 (17), p.3180-3184

2010

Volltextzugriff (PDF)

Novel ZEB2-BCL11B Fusion Gene Identified by RNA-Sequencing in Acute Myeloid Leukemia with t(2;14)(q22;q32)

PloS one, 2015-07, Vol.10 (7), p.e0132736-e0132736

2015

Volltextzugriff (PDF)

Proteomics uncovers molecular features for relapse risk stratification in patients with diffuse large B-cell lymphoma

Blood cancer journal (New York), 2023-10, Vol.13 (1), p.161-161, Article 161

2023

Volltextzugriff (PDF)

Folliculotropic Mycosis Fungoides with Skewed T-cell Receptor CDR3 Motif: Suggestive of Lipid-antigen Selection?

Acta dermato-venereologica, 2017-10, Vol.97 (9), p.1081-1086

2017

Volltextzugriff (PDF)

N-cadherin in neuroblastoma disease: expression and clinical significance

PloS one, 2012-02, Vol.7 (2), p.e31206-e31206

2012

Volltextzugriff (PDF)

Human cytomegalovirus and Epstein-Barr virus in apical and marginal periodontitis: A role in pathology

Journal of medical virology, 2008-06, Vol.80 (6), p.1007-1011

2008

Volltextzugriff (PDF)

Combining MYC, BCL2 and TP53 gene and protein expression alterations improves risk stratification in diffuse large B-cell lymphoma

Leukemia & lymphoma, 2015-06, Vol.56 (6), p.1742-1749

2015

Volltextzugriff (PDF)

The DLBCL90 gene‐expression assay identifies double‐hit lymphomas with high sensitivity in patients from two phase II clinical trials with high‐risk diffuse large B‐cell lymphoma

EJHaem, 2021-02, Vol.2 (1), p.107-111

2021

Volltextzugriff (PDF)

Age Inherently Links to Histology to Define Histoprognostic Classification of Peripheral Neuroblastic Tumors

Journal of clinical oncology, 2020-11, Vol.38 (31), p.3719-3720

2020

Volltextzugriff (PDF)

Primary chronic cold agglutinin disease: An update on pathogenesis, clinical features and therapy

Hematology (Luxembourg), 2007-10, Vol.12 (5), p.361-370

2007

Volltextzugriff (PDF)

Fluorescence in situ hybridization (FISH) on touch preparations: a reliable method for detecting loss of heterozygosity at 1p and 19q in oligodendroglial tumors

The American journal of surgical pathology, 2006-07, Vol.30 (7), p.828-837

2006

Volltextzugriff (PDF)

Extra-adrenal composite phaeochromocytoma/neuroblastoma in a 15-month-old child

Journal of pediatric surgery case reports, 2015-08, Vol.3 (8), p.348-350

2015

Volltextzugriff (PDF)

Detecting minimal residual disease in neuroblastoma patients-the present state of the art

Cancer letters, 2005-10, Vol.228 (1), p.229-240

2005

Volltextzugriff (PDF)

1 – 25 von 131

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(127)
Mit Volltextzugriff
(128)

Publikationsform

Artikel
(131)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Evaluation of Deep Learning Architectures for Complex Immunofluorescence Nuclear Image Segmentation

T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized by Reversible Suppression of T-cell Receptor Signaling

Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma

Correction: Whole exome sequencing of high-risk neuroblastoma identifies novel non-synonymous variants

Whole exome sequencing of high-risk neuroblastoma identifies novel non-synonymous variants

Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease forms

Whole exome sequencing of high-risk neuroblastoma identifies novel non-synonymous variants

Early‐phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning Meeting

Evaluation of clinical parameters and biomarkers in older, untreated mantle cell lymphoma patients receiving bendamustine-rituximab

11q Deletion or ALK Activity Curbs DLG2 Expression to Maintain an Undifferentiated State in Neuroblastoma

An annotated fluorescence image dataset for training nuclear segmentation methods

Plasmacytoid Dendritic Cells (Natural Interferon- α/β-Producing Cells) Accumulate in Cutaneous Lupus Erythematosus Lesions

High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease

Novel ZEB2-BCL11B Fusion Gene Identified by RNA-Sequencing in Acute Myeloid Leukemia with t(2;14)(q22;q32)

Proteomics uncovers molecular features for relapse risk stratification in patients with diffuse large B-cell lymphoma

Folliculotropic Mycosis Fungoides with Skewed T-cell Receptor CDR3 Motif: Suggestive of Lipid-antigen Selection?

N-cadherin in neuroblastoma disease: expression and clinical significance

Human cytomegalovirus and Epstein-Barr virus in apical and marginal periodontitis: A role in pathology

Combining MYC, BCL2 and TP53 gene and protein expression alterations improves risk stratification in diffuse large B-cell lymphoma

The DLBCL90 gene‐expression assay identifies double‐hit lymphomas with high sensitivity in patients from two phase II clinical trials with high‐risk diffuse large B‐cell lymphoma

Age Inherently Links to Histology to Define Histoprognostic Classification of Peripheral Neuroblastic Tumors

Primary chronic cold agglutinin disease: An update on pathogenesis, clinical features and therapy

Fluorescence in situ hybridization (FISH) on touch preparations: a reliable method for detecting loss of heterozygosity at 1p and 19q in oligodendroglial tumors

Extra-adrenal composite phaeochromocytoma/neuroblastoma in a 15-month-old child

Detecting minimal residual disease in neuroblastoma patients-the present state of the art

Suchergebnisse filtern